For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241219:nRSS6656Qa&default-theme=true
RNS Number : 6656Q MicroSalt PLC 19 December 2024
This is a Reach announcement, and the information contained is not considered
to be material or to have a significant impact on management's expectations of
the Company's performance.
19 December 2024
MicroSalt plc
("MicroSalt" or the "Company")
MicroSalt Files New Patent and Secures Placement with Carma Hospitality
MicroSalt plc (AIM: SALT), a pioneer in full-flavor, natural salt with
approximately 50% less sodium, is excited to announce the filing of a new
patent application with the United States Patent and Trademark Office (USPTO).
This patent application covers innovative methods, systems, and compositions
for creating granulated salt from powdered salt formulations. The new
development is specifically tailored for the food service industry, with a
focus on fried foods such as French fries and fish.
The global French fry market, currently valued at approximately US$16.6
billion, is projected to reach $21.9 billion by 2030. 1 (#_ftn1) MicroSalt's
new formulation ensures seasoning distribution and enhanced flowability,
solving a key challenge in the effort to reduce sodium content in this
fast-growing segment of the foodservice industry. There are 548,062 global
fast food restaurants businesses as of 2024 2 (#_ftn2) , with the majority
offering French fries.
Rick Guiney, CEO of MicroSalt, commented:
"This patent filing marks an additional major milestone in our mission to
reduce sodium consumption globally. Our dedication to research and development
has led to a breakthrough that enables us to bring the low-sodium benefits of
MicroSalt to the entire foodservice sector. With this new formulation, we are
addressing a critical need in the French fry industry, which continues to
expand rapidly."
In addition, MicroSalt has achieved an important endorsement from Carma
Hospitality, a forward-thinking restaurant chain based in Montreal, Canada.
Carma Hospitality has integrated MicroSalt's new formula into its operations,
highlighting its effectiveness in maintaining consistent seasoning across
various workstations and shift changes.
Mike Zaki, Co-founder of Carma Hospitality, stated:
"This advanced formula from MicroSalt has revolutionized our kitchen
operations. It allows us to reduce sodium while ensuring consistent seasoning
throughout our entire workflow. MicroSalt's solution has been instrumental in
helping us achieve our sodium reduction goals while maintaining the quality
our customers expect."
For more information, please visit www.microsaltinc.co
(http://www.microsaltinc.co) m, follow on X @MicroSaltPLC or contact:
MicroSalt plc Via Flagstaff PR
Rick Guiney, CEO
Flagstaff PR (Financial PR) +44 (0)20 7129 1474
Tim Thompson / Alison Allfrey / Anna Probert
microsalt@flagstaffcomms.com (mailto:microsalt@flagstaffcomms.com)
( )
About Carma Hospitality
Since 2016, Carma Hospitality has been an extraordinary hospitality group that
brings a diverse range of culinary experiences to life in the Greater Montreal
and Old Port areas. With over 13 distinct restaurants, each boasting its own
unique ambiance and culinary expertise, Carma Hospitality invites you on a
captivating journey through Italian delicacies, succulent seafood, vibrant
Mexican flavors, sizzling steaks, and refined Japanese omakase. Our commitment
to excellence, innovation, and unforgettable dining experiences has made us a
cornerstone of the Montreal culinary scene.
https://carmahospitality.com/team/ (https://carmahospitality.com/team/)
About MicroSalt®
MicroSalt® produces a patented full-flavour, low-sodium salt for food
manufacturers and consumers.
MicroSalt is a major potential disruptor in the food market, thanks to its
micro-sized particles which deliver the same sense of saltiness to a wide
range of foods but with approximately 50% less sodium. Excess sodium
consumption is a significant contributor to cardiovascular disease and
MicroSalt's solution meets the rising demand for healthier alternatives to
traditional salt. The WHO has set a target for reducing global sodium intake
by 30% by 2025, which it estimates will save 7 million lives by 2030.
Each year, cardiovascular disease costs the UK £19 billion - if the average
salt intake was reduced by one gram per day, it has been estimated that 4,147
lives and £288 million would be saved each year in the UK. As a nation, the
UK consumes 183 million kilograms of salt each year, and 70 per cent. of the
typical person's sodium intake is hidden in processed foods.
MicroSalt uses its patented technology to help create a high barrier to entry
within the reduced-sodium salt market. The group has multiple US patents and
applications on its core products, plus issued patents in China, Mexico, and
Australia along with multiple patent applications pending in other
jurisdictions globally.
The Directors believe that MicroSalt is well positioned to capture growth in
the low sodium market, which is expected to grow exponentially, and that there
is also scope to enter the larger salt market.
MicroSalt has a three-pronged marketing strategy, targeting large B2B food
manufacturers, the B2C market and e-commerce customers. MicroSalt's all
natural, low-sodium solution is well positioned to take advantage of the
fast-growing market for a healthier alternative to traditional salt.
ENDS
1 (#_ftnref1) https://www.kbvresearch.com/press-release/french-fries-market/
2 (#_ftnref2)
https://www.ibisworld.com/global/number-of-businesses/global-fast-food-restaurants/1480/#:~:text=There%20are%20548%2C062%20Global%20Fast,increase%20of%200.5%25%20from%202023.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END NRATPBMTMTBBTII